MMR vaccination rate children U.S. 1995-2017

Bitte beachten Sie, dass die von Ihnen aufgerufene Seite nicht in Ihrer Standardsprache vorliegt. Sie nutzen unsere Plattform nun in einer anderen Sprache.

As of 2017, around 91.5 percent of children in the U.S. aged 19 to 35 months had been vaccinated against measles, mumps and rubella (MMR). The MMR vaccine is widely used around the world and is recommended by the Centers for Disease Control and Prevention (CDC) for adults who don’t have immunity and all children.

Measles

The number of cases of measles in the United States has dropped significantly since the introduction of the MMR vaccination. However, there has been a recent increase in measles cases, due to the growth of the vaccine hesitancy movement. Despite claims from this movement, the MMR vaccine is safe and effective. One dose of the MMR vaccine is around 93 percent effective against measles, while two doses is 97 percent effective.

Mumps

The MMR vaccine has resulted in a similar decrease in the rate of mumps cases in the U.S. One dose of the MMR vaccine is 78 percent effective against mumps, while two doses is 88 percent effective. Although the MMR vaccine is safe and effective, like any medicine it can have side effects. Common side effects include fever, a mild rash and temporary joint pain and stiffness.

Percentage of children aged 19-35 months who are vaccinated against measles, mumps and rubella (MMR) in the U.S. from 1995 to 2017

Characteristic	Immunization rate
2017	91.5%
2016	91.1%
2015	91.9%
2014	91.5%
2013*	91.9%
2012	90.8%
2011	91.6%
2010	91.5%
2009	90%
2008	92.1%
2007	92.3%
2006	92.3%
2005	91.5%
2004	93%
2003	93%
2002	91.6%
2001	91.4%
2000	90.5%
1999	91.5%
1998	92%
1997	90.5%
1996	90.7%
1995	87.8%